"Mad Money" host Jim Cramer says investors should sell their stock in a company when its CEO, CFO or other executives quit. In these situations, Cramer breaks from his usual method of doing homework.
As news emerges of Amazon considering a big push into pharmaceuticals , CNBC's Jim Cramer endorsed one of his favorite drugmakers, Celgene (NASDAQ: CELG) , after its stock fell off a cliff on Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback